Necdin, a Prader-Willi syndrome candidate gene, regulates gonadotropin-releasing hormone neurons during development

Human Molecular Genetics

Volumn 18, Issue 2, 2009, Pages 248-260

  Miller, Nichol L G ^a   Wevrick, Rachel ^b   Mellon, Pamela L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; NECDIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MSX; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; ENHANCER REGION; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; HORMONE RELEASE; HYPOGONADOTROPIC HYPOGONADISM; IMMUNOPRECIPITATION; MOUSE; NERVE CELL DIFFERENTIATION; NERVE GROWTH; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GONADOTROPIN-RELEASING HORMONE; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NERVOUS SYSTEM; NEURONS; NUCLEAR PROTEINS; PRADER-WILLI SYNDROME; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

MUS;

EID: 58049209787     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn344     Document Type: Article

References (51)

1. Goldstone, A.P. (2004) Prader-Willi syndrome: Advances in genetics, pathophysiology and treatment. Trends Endocrinol. Metab., 15 12-20.
2. Gunay-Aygun, M., Schwartz, S., Heeger, S., O'Riordan, M.A. and Cassidy, S.B. (2001) The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics, 108, E92.
3. Taniura, H., Kobayashi, M. and Yoshikawa, K. (2005) Functional domains of necdin for protein-protein interaction, nuclear matrix targeting, and cell growth suppression. J. Cell. Biochem., 94, 804-815.
4. Barker, P.A. and Salehi, A. (2002) The MAGE proteins: Emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J. Neurosci. Res., 67, 705-712.
5. Ding, F., Prints, Y., Dhar, M.S., Johnson, D.K., Garnacho-Montero, C., Nicholls, R.D. and Francke, U. (2005) Lack of Pwcr1/MBII-85 snoRNA is critical for neonatal lethality in Prader-Willi syndrome mouse models. Mamm. Genome, 16, 424-431.
6. Stefan, M., Ji, H., Simmons, R.A., Cummings, D.E., Ahima, R.S., Friedman, M.I. and Nicholls, R.D. (2005) Hormonal and metabolic defects in a Prader-Willi syndrome mouse model with neonatal failure to thrive. Endocrinology, 146, 4377-4385.
7. Gabriel, J.M., Merchant, M., Ohta, T., Ji, Y., Caldwell, R.G., Ramsey, M.J., Tucker, J.D., Longnecker, R. and Nicholls, R.D. (1999) A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and angelman syndromes. Proc. Natl Acad. Sci. USA, 96, 9258-9263.
8. Chamberlain, S.J., Johnstone, K.A., DuBose, A.J., Simon, T.A., Bartolomei, M.S., Resnick, J.L. and Brannan, C.I. (2004) Evidence for genetic modifiers of postnatal lethality in PWS-IC deletion mice. Hum. Mol. Genet., 13, 2971-2977.
9. Yang, T., Adamson, T.E., Resnick, J.L., Leff, S., Wevrick, R., Francke, U., Jenkins, N.A., Copeland, N.G. and Brannan, C.I. (1998) A mouse model for Prader-Willi syndrome imprinting-centre mutations. Nat. Genet. 19, 25-31.
10. Kuwako, K., Hosokawa, A., Nishimura, I., Uetsuki, T., Yamada, M., Nada, S., Okada, M. and Yoshikawa, K. (2005) Disruption of the paternal necdin gene diminishes TrkA signaling for sensory neuron survival. J. Neurosci., 25, 7090-7099.
11. Takazaki, R., Nishimura, I. and Yoshikawa, K. (2002) Necdin is required for terminal differentiation and survival of primary dorsal root ganglion neurons. Exp. Cell Res., 277, 220-322.
12. Skryabin, B.V., Gubar, L.V., Seeger, B., Pfeiffer, J., Handel, S., Robeck, T., Karpova, E., Rozhdestvensky, T.S. and Brosius, J. (2007) Deletion of the MBII-85 snoRNA gene cluster in mice results in postnatal growth retardation. PLoS Genet., 3, e235.
13. Ren, J., Lee, S., Pagliardini, S., Gerard, M., Stewart, C.L., Greer, J.J. and Wevrick, R. (2003) Absence of Ndn, encoding the Prader-Willi syndrome-deleted gene necdin, results in congenital deficiency of central respiratory drive in neonatal mice. J. Neurosci., 23 1569-1573.
14. Gerard, M., Hernandez, L., Wevrick, R. and Stewart, C.L. (1999) Disruption of the mouse necdin gene results in early post-natal lethality. Nat. Genet., 23, 199-202.
15. Muscatelli, F., Abrous, D.N., Massacrier, A., Boccaccio, I., Le Moal, M., Cau, P. and Cremer, H. (2000) Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum. Mol. Genet., 9, 3101-3110.
16. Tsai, T.F., Armstrong, D. and Beaudet, A.L. (1999) Necdin-deficient mice do not show lethality or the obesity and infertility of Prader-Willi syndrome. Nat. Genet., 22, 15-16.
17. Kuwajima, T., Taniura, H., Nishimura, I. and Yoshikawa, K. (2004) Necdin interacts with the Msx2 homeodomain protein via MAGE-D1 to promote myogenic differentiation of C2C12 cells. J. Biol. Chem., 279 40484-40493.
18. Lee, S., Walker, C.L., Karten, B., Kuny, S.L., Tennese, A.A., O'Neill, M.A. and Wevrick, R. (2005) Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth. Hum. Mol. Genet., 14, 627-637.
19. Tennese, A.A., Gee, C.B. and Wevrick, R. (2008) Loss of the Prader-Willi syndrome protein necdin causes defective migration, axonal outgrowth, and survival of embryonic sympathetic neurons. Dev. Dyn., 237 1935-1943.
20. Kruger, M., Ruschke, K. and Braun, T. (2004) NSCL-1 and NSCL-2 synergistically determine the fate of GnRH-1 neurons and control necdin gene expression. EMBO J., 23, 4353-6443.
21. Good, D.J., Porter, F.D., Mahon, K.A., Parlow, A.F., Westphal, H. and Kirsch, I.R. (1997) Hypogonadism and obesity in mice with a targeted deletion of the Nhlh2 gene. Nat. Genet., 15, 397-401.
22. Wray, S., Grant, P. and Gainer, H. (1989) Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proc. Natl Acad. Sci. USA 86, 8132-8136.
23. Schwanzel-Fukuda, M. and Pfaff, D.W. (1989) Origin of luteinizing hormone-releasing hormone neurons. Nature, 338, 161-164.
24. Schwanzel-Fukuda, M., Jorgenson, K.L., Bergen, H.T., Weesner, G.D. and Pfaff, D.W. (1992) Biology of normal luteinizing hormone-releasing hormone neurons during and after their migration from olfactory placode. Endocrinol. Rev., 13, 623-634.
25. Simonian, S.X. and Herbison, A.E. (2001) Regulation of gonadotropin-releasing hormone (GnRH) gene expression during GnRH neuron migration in the mouse. Neuroendocrinology, 73, 149-156.
26. Givens, M.L., Rave-Harel, N., Goonewardena, V.D., Kurotani, R., Berdy, S.E., Swan, C.H., Rubenstein, J.L., Robert, B. and Mellon, P.L. (2005) Developmental regulation of gonadotropin-releasing hormone gene expression by the MSX and DLX homeodomain protein families. J. Biol. Chem., 280, 19156-19165.
27. Masuda, Y., Sasaki, A., Shibuya, H., Ueno, N., Ikeda, K. and Watanabe, K. (2001) Dlxin-1, a novel protein that binds Dlx5 and regulates its transcriptional function. J. Biol. Chem., 276, 5331-5338.
28. Brunelli, S., Tagliafico, E., De Angelis, F.G., Tonlorenzi, R., Baesso, S., Ferrari, S., Niinobe, M., Yoshikawa, K., Schwartz, R.J., Bozzoni, I. et al. (2004) Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells. Circ. Res., 94, 1571-1578.
29. Burman, P., Ritzen, E.M. and Lindgren, A.C. (2001) Endocrine dysfunction in Prader-Willi syndrome: A review with special reference to GH. Endocr. Rev., 22, 787-799.
30. Mellon, P.L., Windle, J.J., Goldsmith, P., Pedula, C., Roberts, J. and Weiner, R.I. (1990) Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron, 5, 1-10.
31. Wetsel, W.C., Valença, M.M., Merchenthaler, I., Liposits, Z., López, F.J., Weiner, R.I., Mellon, P.L. and Negro-Vilar, A. (1992) Intrinsic pulsatile secretory activity of immortalized LHRH secreting neurons. Proc. Natl Acad. Sci. USA, 89, 4149-4153.
32. Silverman, A.J., Roberts, J.L., Dong, K.W., Miller, G.M. and Gibson, M.J. (1992) Intrahypothalamic injection of a cell line secreting gonadotropin-releasing hormone results in cellular differentiation and reversal of hypogonadism in mutant mice. Proc. Natl Acad. Sci. USA 89, 10668-10672.
33. Radovick, S., Wray, S., Lee, E., Nicols, D.K., Nakayama, Y., Weintraub, B.D., Westphal, H., Cutler, GB Jr and Wondisford, F.E. (1991) Migratory arrest of gonadotropin-releasing hormone neurons in transgenic mice. Proc. Natl Acad. Sci. USA, 88, 3402-3406.
34. Hsiao, A., Worrall, D.S., Olefsky, J.M. and Subramaniam, S. (2004) Variance-modeled posterior inference of microarray data: Gene-expression changes in 3T3-L1 adipocytes. Bioinformatics, 20, 3108-3127.
35. Alarid, E.T., Windle, J.J., Whyte, D.B. and Mellon, P.L. (1996) Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. Development, 122, 3319-3329.
36. Givens, M.L., Kurotani, R., Rave Harel, N., Miller, N.L.G. and Mellon, P.L. (2004) Phylogenetic footprinting reveals functional upstream regions of the gonadotropin-releasing hormone gene that enhance cell-specific expression. Mol. Endocrinol., 18, 2950-2966.
37. Matsumoto, K., Taniura, H., Uetsuki, T. and Yoshikawa, K. (2001) Necdin acts as a transcriptional repressor that interacts with multiple guanosine clusters. Gene, 272, 173-179.
38. Rave-Harel, N., Miller, N.L.G., Givens, M.L. and Mellon, P.L. (2005) The Groucho-related gene family regulates the gonadotropin-releasing hormone gene through interaction with the homeodomain proteins MSX1 and OCT1. J. Biol. Chem., 280, 30975-30983.
39. Matsuda, T., Suzuki, H., Oishi, I., Kani, S., Kuroda, Y., Komori, T., Sasaki, A., Watanabe, K. and Minami, Y. (2003) The receptor tyrosine kinase Ror2 associates with the melanoma-associated antigen (MAGE) family protein Dlxin-1 and regulates its intracellular distribution. J. Biol. Chem., 278, 29057-29064.
40. Eiholzer, U., l'Allemand, D., Rousson, V., Schlumpf, M., Gasser, T., Girard, J., Gruters, A. and Simoni, M. (2006) Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart-Willi syndrome. J. Clin. Endocrinol. Metab., 91, 892-898.
41. Andrieu, D., Watrin, F., Niinobe, M., Yoshikawa, K., Muscatelli, F. and Fernandez, P.A. (2003) Expression of the Prader-Willi gene Necdin during mouse nervous system development correlates with neuronal differentiation and p75NTR expression. Gene Expr. Patterns, 3 761-765.
42. Yoshikawa, K. (2000) Cell cycle regulators in neural stem cells and postmitotic neurons. Neurosci. Res., 37, 1-14.
43. Aizawa, T., Maruyama, K., Kondo, H. and Yoshikawa, K. (1992) Expression of necdin, an embryonal carcinoma-derived nuclear protein, in developing mouse brain. Brain Res. Dev. Brain Res., 68, 265-274.
44. Lee, S., Walker, C.L. and Wevrick, R. (2003) Prader-Willi syndrome transcripts are expressed in phenotypically significant regions of the developing mouse brain. Gene Expr. Patterns, 3, 599-609.
45. Kendall, S.K., Samuelson, L.C., Saunders, T.L., Wood, R.I. and Camper, S.A. (1995) Targeted disruption of the pituitary glycoprotein hormone α-subunit produces hypogonadal and hypothyroid mice. Genes Dev., 9, 2007-2018.
46. Luo, X., Ikeda, Y. and Parker, K.L. (1994) A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell, 77, 481-490.
47. Gill, J.C., Wadas, B., Chen, P., Portillo, W., Reyna, A., Jorgensen, E., Mani, S., Schwarting, G.A., Moenter, S.M., Tobet, S. et al. (2008) The gonadotropin-releasing hormone (GnRH) neuronal population is normal in size and distribution in GnRH-deficient and GnRH receptor-mutant hypogonadal mice. Endocrinology, 149, 4596-4604.
48. Herbison, A.E., Porteous, R., Pape, J.R., Mora, J.M. and Hurst, P.R. (2008) Gonadotropin-releasing hormone (GnRH) neuron requirements for puberty, ovulation and fertility. Endocrinology, 149, 597-604.
49. Pitteloud, N., Quinton, R., Pearce, S., Raivio, T., Acierno, J., Dwyer, A., Plummer, L., Hughes, V., Seminara, S., Cheng, Y.Z. et al. (2007) Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J. Clin. Invest., 117, 457-463.
50. Zhang, H., Bailey, J.S., Coss, D., Lin, B., Tsutsumi, R., Lawson, M.A., Mellon, P.L. and Webster, N.J. (2006) Activin modulates the transcriptional response of LbT2 cells to GnRH and alters cellular proliferation. Mol. Endocrinol., 20, 2909-2930.
51. Lawson, M.A., Tsutsumi, R., Zhang, H., Talukdar, I., Butler, B.K., Santos, S.J., Mellon, P.L. and Webster, N.J. (2007) Pulse sensitivity of the luteinizing hormone beta promoter is determined by a negative feedback loop Involving early growth response-1 and Ngfi-A binding protein 1 and 2. Mol. Endocrinol., 21, 1175-1191.